España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Novartis
NVS
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$109.35
2.04
1.90%
At close: -
$109.35
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Novartis (NVS) Forecast
News
Earnings
Novartis (NVS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Novartis (NYSE:NVS) Stock
Novartis Stock (NYSE: NVS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, February 13, 2025
U.S. CDC Report: Evidence Found Of Recent Bir...
Benzinga Newsdesk
Novartis Gets Health Canada Approval For Fabh...
Benzinga Newsdesk
This Kraft Heinz Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
Avi Kapoor
UBS Downgrades Novartis to Neutral
Benzinga Newsdesk
Tuesday, February 11, 2025
Novartis To Beef Up Heart Disease Offering With $3 Billion Blackstone-Backed Anthos Therapeutics Deal
Vandana Singh
Blackstone-Backed Anthos Therapeutics To Be A...
Benzinga Newsdesk
Monday, February 10, 2025
Super Bowl Commercials 2025: Complete List of Super Bowl LIX Ads And Companies Behind Them
Chris Katje
Friday, February 07, 2025
Super Bowl LIX Commercials: AI, Celebs, Muppets, Warren Buffett-Linked Brand Take The Spotlight
Chris Katje
Tuesday, February 04, 2025
Novartis CEO Says Co Sets High Bar In Pursuit...
Benzinga Newsdesk
Friday, January 31, 2025
US Stock Futures Climb After Apple Beats Q1 Expectations: Expert Says Tech Stocks Hold Above Key Level Despite DeepSeek Impact
Rishabh Mishra
Novartis Q4 Earnings: Revenue And EPS Beat, CEO Dismisses Entresto Patent Expiration Worries
Nabaparna Bhattacharya
Earnings Scheduled For January 31, 2025
Benzinga Insights
Novartis Proposes 6.1% Dividend Increase To C...
Benzinga Newsdesk
Novartis Expects 2025 Sales Growth Of Mid- To...
Benzinga Newsdesk
Novartis Q4 2024 Adj. EPS $1.98 Beats $1.81 E...
Benzinga Newsdesk
Thursday, January 30, 2025
AbbVie Vs. Novartis: Which Has The Technical Edge Before Q4 Earnings?
Surbhi Jain
Wednesday, January 29, 2025
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
Anthony Noto
Wednesday, January 22, 2025
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Vandana Singh
FDA Adds Boxed Warning About Anaphylaxis With...
Benzinga Newsdesk
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
Kaustubh Bagalkote
Thursday, January 16, 2025
U.S. FDA Chief Califf Says Current Regulation...
Benzinga Newsdesk
Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug
Vandana Singh
'As Bird Flu Affects More People And Animals,...
Benzinga Newsdesk
Monday, January 13, 2025
The US Court Of Appeals For The Federal Circu...
Benzinga Newsdesk
Illumina Launches Proteomics Pilot with 50,00...
Benzinga Newsdesk
Friday, January 10, 2025
Intra-Cellular Therapies Enters Settlement Ag...
Benzinga Newsdesk
Wednesday, January 08, 2025
Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development (CORRECTED)
Vandana Singh
Monday, January 06, 2025
'LDH Reports First U.S. H5N1-Related Human De...
Benzinga Newsdesk
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
Vandana Singh
Monday, December 30, 2024
Reported Earlier, Novartis Reports Topline Re...
Benzinga Newsdesk
Thursday, December 19, 2024
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Vandana Singh
Wednesday, December 18, 2024
CA Governor Newsom Proclaimed State Of Emerge...
Benzinga Newsdesk
CDC Confirms First Severe Case Of H5N1 Bird F...
Benzinga Newsdesk
BioAge Labs Announces Multi-Year Collaboratio...
Benzinga Newsdesk
Friday, December 13, 2024
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Vandana Singh
Monday, December 09, 2024
On Saturday, Novartis Announced Longer-term R...
Benzinga Newsdesk
Friday, December 06, 2024
Novartis Touts Encouraging Data From Late-Stage Study For Fabhalta In Rare Type Of Blood Disorder
Vandana Singh
Reuters Agriculture & Energy Policy Reporter ...
Benzinga Newsdesk
Novartis Announced Topline Results From The A...
Benzinga Newsdesk
Tuesday, December 03, 2024
Janux Therapeutics' Prostate Cancer Trial Data Exceeds Investor Expectations: Analyst
Vandana Singh
Monday, December 02, 2024
PTC Therapeutics Inks Licensing Pact With Novartis Worth Up To ~$3 Billion For Huntington's Program
Vandana Singh
Olema Pharmaceuticals Announced A New Clinica...
Benzinga Newsdesk
PTC Therapeutics Signed An Exclusive Global L...
Benzinga Newsdesk
PTC Therapeutics Signs Exclusive Global Licen...
Benzinga Newsdesk
Wednesday, November 27, 2024
The European Commission Has Approved Novartis...
Benzinga Newsdesk
Thursday, November 21, 2024
Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
Vandana Singh
Novartis Upgrades Its Mid-term Guidance. Prev...
Benzinga Newsdesk
Wednesday, November 20, 2024
Vyriad Announces Strategic Collaboration With...
Benzinga Newsdesk
Tuesday, November 19, 2024
Erste Group Downgrades Novartis to Hold
Benzinga Newsdesk
Monday, November 18, 2024
U.S. CDC Says Since April Confirmed Avian Inf...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch